Antiviral Therapies for Adults With Mild to Moderate COVID-19 Infection

JAMA 2026

View at publisher
Authors: Peggy B. Leung, Andrew M. Davis, Kristen Marks
DOI: 10.1001/jama.2026.6918
Cited by: 1
References: 6

Abstract

This JAMA Clinical Guidelines Synopsis summarizes the 2025 Infectious Diseases Society of America (IDSA) updated recommendations on antiviral treatment for mild to moderate COVID-19 in adults.

Fields of Study & Subjects

COVID-19 Clinical Research Studies SARS-CoV-2 and COVID-19 Research Respiratory viral infections research

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
336
Issue
6
Pages
510–510
Publication date
30 June 2026
Language
EN